Our collaborator from the Cento Hospital Universitário de Lisboa Central (Hospital Curry Cabral) presented an oral communication and discussed our work on predicting relapse after liver transplantation to treat hepatocellular carcinoma at the 28th anual meeting of the European Surgical Association. Lots of discussion and interest.
Related Posts
After a lot of under the hood work, we are happy to announce Version 2.0 of the HepatoPredict kit, more
Ophiomics was founded in 2015 as clinical testing laboratory. In 2020, with the support of the EIC Accelerator grant and
🚀Off to #ArabHealth2023 with the #EUeic Overseas Trade Fairs ✈️Programme 2.0! Pay us a visit at the European Pavilion (Za’abeel Hall 6 – Booth Z6.C25).
+351 211 369 829 
